*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect - as a primary diagnosis code | C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 9.53 | |
| Readmission Rate (%) | 31.51 | |
| Unplanned Readmission Rate (%) | NA | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 011: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 012: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|
| Total Hospitalizations at DRG | 5,676 | |
| Total Hospitalizations with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | 21 | |
| DRG Share of Total Hospitalizations | 0.02 | |
| % of Total ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect in DRG | 35.0 | |
| Avg LOS at DRG | 13.29 | |
| Avg LOS with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | 16.24 | |
| Readmission Rate at DRG | 39.33 | |
| Readmission Rate with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | NA | |
| Unplanned Readmission Rate at DRG | 14.94 | |
| Unplanned Readmission Rate with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | NA | |
| Total Medicare payments at DRG | $228,782,019 | |
| Total Medicare payments with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | $786,385 | |
| Total Medicare payment per Day at DRG | $3,033 | |
| Total Medicare payment per Day with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | $2,306 | |
| Total Medicare payment per Hospitalization at DRG | $40,307 | |
| Total Medicare payment per Hospitalization with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | $37,447 | |
| Total Medicare Charges at DRG | $1,036,941,744 | |
| Total Medicare Charges with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | $4,797,473 | |
| Avg Charges at DRG | $182,689 | |
| Avg Charges with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | $228,451 | |
| Mortality Rate at DRG | 2.59 | |
| Mortality Rate with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | NA | |
| SNF Discharge Rate at DRG | 23.11 | |
| SNF Discharge Rate with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | NA | |
| Home Discharge Rate at DRG | 14.76 | |
| Home Discharge Rate with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 011: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 012: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 004: TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITHOUT MAJOR O.R. PROCEDURE | DRG 146: EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 147: EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 5,676 | ||||
| Total Hospitalizations with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | 54 | ||||
| DRG Share of Total Hospitalizations | 0.02 | ||||
| % of Total ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect in DRG | 21.69 | ||||
| Avg LOS at DRG | 13.29 | ||||
| Avg LOS with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | 14.89 | ||||
| Readmission Rate at DRG | 39.33 | ||||
| Readmission Rate with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | 44.9 | ||||
| Unplanned Readmission Rate at DRG | 14.94 | ||||
| Unplanned Readmission Rate with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | NA | ||||
| Total Medicare payments at DRG | $228,782,019 | ||||
| Total Medicare payments with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | $2,069,259 | ||||
| Total Medicare payment per Day at DRG | $3,033 | ||||
| Total Medicare payment per Day with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | $2,574 | ||||
| Total Medicare payment per Hospitalization at DRG | $40,307 | ||||
| Total Medicare payment per Hospitalization with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | $38,320 | ||||
| Total Medicare Charges at DRG | $1,036,941,744 | ||||
| Total Medicare Charges with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | $9,466,875 | ||||
| Avg Charges at DRG | $182,689 | ||||
| Avg Charges with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | $175,313 | ||||
| Mortality Rate at DRG | 2.59 | ||||
| Mortality Rate with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | NA | ||||
| SNF Discharge Rate at DRG | 23.11 | ||||
| SNF Discharge Rate with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | 25.93 | ||||
| Home Discharge Rate at DRG | 14.76 | ||||
| Home Discharge Rate with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 129: MAJOR HEAD AND NECK PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) OR MAJOR DEVICE | |
|---|---|
| Total Hospitalizations at DRG | 6,332 |
| Total Hospitalizations with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | 11 |
| DRG Share of Total Hospitalizations | 0.02 |
| % of Total ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect in DRG | 4.42 |
| Avg LOS at DRG | 5.14 |
| Avg LOS with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | 6.18 |
| Readmission Rate at DRG | 14.35 |
| Readmission Rate with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | NA |
| Unplanned Readmission Rate at DRG | 7.64 |
| Unplanned Readmission Rate with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | NA |
| Total Medicare payments at DRG | $113,818,459 |
| Total Medicare payments with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | $226,509 |
| Total Medicare payment per Day at DRG | $3,496 |
| Total Medicare payment per Day with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | $3,331 |
| Total Medicare payment per Hospitalization at DRG | $17,975 |
| Total Medicare payment per Hospitalization with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | $20,592 |
| Total Medicare Charges at DRG | $599,317,955 |
| Total Medicare Charges with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | $1,330,036 |
| Avg Charges at DRG | $94,649 |
| Avg Charges with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | $120,912 |
| Mortality Rate at DRG | 0.74 |
| Mortality Rate with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | NA |
| SNF Discharge Rate at DRG | 9.41 |
| SNF Discharge Rate with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | NA |
| Home Discharge Rate at DRG | 64.53 |
| Home Discharge Rate with ICD C131 - Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect | NA |